| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
9,230,000 |
| Market
Cap: |
3.60(M) |
| Last
Volume: |
426,351 |
Avg
Vol: |
425,192 |
| 52
Week Range: |
$0.39 - $0.39 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Cyclacel Pharmaceuticals is a clinical-stage biopharmaceutical company working to develop cancer medicines based on cell cycle, transcriptional regulation and mitosis control biology. The transcriptional regulation program is evaluating fadraciclib, a Cyclin Dependent Kinase 2/9 (CDK2/9) inhibitor, in solid tumors and hematological malignancies. The anti-mitotic program is evaluating CYC140, a Polo-Like-Kinase 1(PLK 1) inhibitor, in cancers. CDKs are a family of enzymes discovered as regulators of the cell cycle. PLK1 is a serine/threonine kinase with a central role in cell division, or the mitotic phase of the cell cycle, and is a regulator of the DNA damage checkpoint.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
7,956 |
7,956 |
7,956 |
| Total Buy Value |
$0 |
$26,374 |
$26,374 |
$26,374 |
| Total People Bought |
0 |
2 |
2 |
2 |
| Total Buy Transactions |
0 |
2 |
2 |
2 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-14 |
2023-12-12 |
2023-06-13 |
2022-06-13 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Morgan Stanley |
10% Owner |
– – • |
2008-03-04 |
4 |
B |
$4.08 |
$775,200 |
I/I |
190,000 |
3,259,824 |
1.5 |
- |
|
| Rombotis Spiro |
President & C.E.O. |
• • – |
2007-12-20 |
4 |
B |
$5.47 |
$5,470 |
D/D |
1,000 |
358,848 |
2.81 |
- |
|
| Rombotis Spiro |
President & C.E.O. |
• • – |
2007-12-19 |
4 |
B |
$5.48 |
$7,672 |
D/D |
1,400 |
357,848 |
2.81 |
- |
|
| Morgan Stanley |
10% Owner |
– – • |
2007-10-16 |
4 |
B |
$5.47 |
$402,889 |
I/I |
73,380 |
3,075,524 |
1.5 |
- |
|
| Morgan Stanley |
10% Owner |
– – • |
2007-08-01 |
4 |
B |
$4.80 |
$1,680,000 |
I/I |
350,000 |
3,002,144 |
1.5 |
- |
|
| Morgan Stanley |
10% Owner |
– – • |
2007-08-01 |
4 |
S |
$5.15 |
$7,210 |
I/I |
(1,400) |
2,652,144 |
|
- |
|
| Morgan Stanley |
10% Owner |
– – • |
2007-08-01 |
4 |
S |
$5.17 |
$7,238 |
I/I |
(1,400) |
2,653,544 |
|
- |
|
| Morgan Stanley |
10% Owner |
– – • |
2007-07-02 |
4 |
S |
$6.50 |
$298,350 |
I/I |
(45,900) |
2,654,944 |
|
- |
|
| Morgan Stanley |
10% Owner |
– – • |
2007-07-02 |
4 |
S |
$6.50 |
$298,350 |
I/I |
(45,900) |
2,700,844 |
|
- |
|
| Morgan Stanley |
10% Owner |
– – • |
2007-06-13 |
4 |
B |
$7.89 |
$953,901 |
I/I |
120,900 |
2,654,944 |
1.5 |
- |
|
| Morgan Stanley |
10% Owner |
– – • |
2007-06-04 |
4 |
S |
$12.00 |
$1,200 |
I/I |
(100) |
2,534,044 |
|
- |
|
| Morgan Stanley |
10% Owner |
– – • |
2007-05-02 |
4 |
B |
$7.70 |
$52,360 |
I/I |
6,800 |
2,534,144 |
1.5 |
- |
|
| Morgan Stanley |
10% Owner |
– – • |
2007-05-01 |
4 |
B |
$7.77 |
$97,125 |
I/I |
12,500 |
2,527,344 |
1.5 |
- |
|
| Morgan Stanley |
10% Owner |
– – • |
2007-04-03 |
4 |
B |
$7.80 |
$129,176 |
I/I |
16,561 |
2,514,844 |
1.5 |
- |
|
| Morgan Stanley |
10% Owner |
– – • |
2007-04-02 |
4 |
B |
$7.67 |
$345,666 |
I/I |
44,739 |
2,498,283 |
1.5 |
- |
|
| Morgan Stanley |
10% Owner |
– – • |
2007-04-02 |
4 |
S |
$7.75 |
$132,525 |
I/I |
(17,100) |
2,453,544 |
|
- |
|
| Morgan Stanley |
10% Owner |
– – • |
2007-03-06 |
4 |
B |
$7.52 |
$12,032 |
I/I |
1,600 |
2,470,644 |
1.5 |
- |
|
| Morgan Stanley |
10% Owner |
– – • |
2007-03-05 |
4 |
B |
$7.60 |
$43,970 |
I/I |
5,700 |
2,469,044 |
1.5 |
- |
|
| Morgan Stanley |
10% Owner |
– – • |
2007-03-02 |
4 |
B |
$7.88 |
$100,076 |
I/I |
12,700 |
2,463,344 |
1.5 |
- |
|
| Morgan Stanley |
10% Owner |
– – • |
2007-03-01 |
4 |
B |
$7.82 |
$20,332 |
I/I |
2,600 |
2,450,644 |
1.5 |
- |
|
| Morgan Stanley |
10% Owner |
– – • |
2007-02-13 |
4 |
B |
$8.44 |
$5,697,000 |
I/I |
675,000 |
2,448,044 |
1.5 |
- |
|
| Morgan Stanley |
10% Owner |
– – • |
2007-02-05 |
4 |
B |
$7.84 |
$144,256 |
I/I |
18,400 |
1,773,044 |
1.5 |
- |
|
| Morgan Stanley |
10% Owner |
– – • |
2007-02-01 |
4 |
S |
$7.85 |
$3,925 |
I/I |
(500) |
1,754,644 |
|
- |
|
| Morgan Stanley |
10% Owner |
– – • |
2007-02-01 |
4 |
B |
$7.80 |
$6,240 |
I/I |
800 |
1,755,144 |
1.5 |
- |
|
| Morgan Stanley |
10% Owner |
– – • |
2007-01-03 |
4 |
B |
$6.86 |
$311,516 |
I/I |
45,400 |
1,754,344 |
1.5 |
- |
|
281 Records found
|
|
Page 7 of 12 |
|
|
